Clinical Trial Update: The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions [NA]

View source ↗

Summary

The ENDEAVOR II trial update notes completion of the study assessing the Endeavor Drug-Eluting Coronary Stent System for coronary artery lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis
• Atherosclerosis
• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Ischemia
• Peripheral Arterial Disease

Drugs mentioned

• Endeavor Drug Eluting Coronary Stent System

Snippet

Sponsor: Medtronic Vascular | Conditions: Coronary Artery Disease, Arterial Occlusive Diseases | NA | Status: COMPLETED